Fig. 1: Identification of IPF lncRNAs signatures.
From: LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation
A Venn diagram of overlapping DE lncRNAs among three groups. B, C Distribution of expression levels for key lncRNAs CTD-2528L19.6 and NR2F1-AS1. *P < 0.05, **P < 0.01 in Student’s t-test. D, E Heatmaps show the global expression levels of IPF pathogenic lncRNAs (D) and IPF progression lncRNAs (E) in GSE24206.
